Compare EWBC & PEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | EWBC | PEN |
|---|---|---|
| Founded | 1998 | 2004 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 15.3B | 12.9B |
| IPO Year | 1998 | 2015 |
| Metric | EWBC | PEN |
|---|---|---|
| Price | $115.77 | $331.70 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 13 | 17 |
| Target Price | $126.54 | ★ $357.33 |
| AVG Volume (30 Days) | ★ 847.4K | 509.9K |
| Earning Date | 04-21-2026 | 04-30-2026 |
| Dividend Yield | ★ 2.73% | N/A |
| EPS Growth | 14.29 | ★ 1155.56 |
| EPS | ★ 9.52 | 4.52 |
| Revenue | $55,316,000.00 | ★ $1,403,665,000.00 |
| Revenue This Year | $13.01 | $14.34 |
| Revenue Next Year | $5.38 | $13.71 |
| P/E Ratio | ★ $12.33 | $73.56 |
| Revenue Growth | 3.12 | ★ 17.50 |
| 52 Week Low | $75.23 | $221.26 |
| 52 Week High | $123.82 | $362.41 |
| Indicator | EWBC | PEN |
|---|---|---|
| Relative Strength Index (RSI) | 61.00 | 44.97 |
| Support Level | $114.38 | $326.58 |
| Resistance Level | $118.19 | $338.99 |
| Average True Range (ATR) | 2.36 | 2.28 |
| MACD | 1.17 | 0.36 |
| Stochastic Oscillator | 80.20 | 47.45 |
East West Bancorp Inc operates in U.S. and Asia. The Bank provides range of personal and commercial banking services to individuals and businesses. In addition to offering traditional deposit products that include personal and business checking and savings accounts, money market, and time deposits, the Bank also offers foreign exchange, treasury management and wealth management services. The Bank has three operating segments, (1) Consumer and Business Banking, (2) Commercial Banking and (3) Treasury and Other. The company generates the majority of its revenue from the Commercial banking segment.
Penumbra Inc is a thrombectomy company focused on developing technologies for challenging medical conditions such as ischemic stroke, venous thromboembolism (including pulmonary embolism), and acute limb ischemia. Its portfolio includes Computer-Assisted Vacuum Thrombectomy (CAVT), which is designed to remove blood clots throughout the body. The company offers products such as the Artemis Neuro Evacuation Device (used for surgical removal of fluid and tissue from the ventricles and cerebrum), Indigo System, Penumbra System Reperfusion Catheter, LANTERN Delivery Microcatheter, Penumbra Smart Coil, and ACE Reperfusion Catheters, among others. The company generates maximum revenue from the sale of its products in the United States, followed by international markets.